Friday Feb 10 | AmericanBankingNews.com
Roth Capital Analysts Downgrade Somaxon Pharmaceuticals Shares to "Neutral"
Somaxon Pharmaceuticals was downgraded by equities research analysts at Roth Capital from a "buy" rating to a "neutral" rating in a research note issued to investors on Friday.
House & Psychology, Episode 22
Ben: "We were in a fight. Doesn't mean she's depressed and it doesn't mean she doesn't love me." House: "Fine, maybe the diary proves nothing.
The pharmaceutical drug Silenor is a tricyclic antidepressant that is also used as a hypnotic to initiate and maintain sleep.
Also on Topix